 David Mirsky
Concepts (399)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 46 | 2025 | 3394 | 3.510 |
Why?
| | Hydrocephalus | 6 | 2023 | 103 | 2.300 |
Why?
| | Prenatal Diagnosis | 7 | 2022 | 194 | 1.970 |
Why?
| | Stroke | 14 | 2022 | 1071 | 1.590 |
Why?
| | Brain | 15 | 2022 | 2673 | 1.400 |
Why?
| | Neuroimaging | 10 | 2024 | 279 | 1.390 |
Why?
| | Craniocerebral Trauma | 5 | 2025 | 151 | 1.340 |
Why?
| | Cerebrospinal Fluid Shunts | 2 | 2020 | 28 | 1.210 |
Why?
| | Child Abuse | 6 | 2025 | 512 | 1.210 |
Why?
| | Tomography, X-Ray Computed | 13 | 2024 | 2512 | 1.120 |
Why?
| | Brain Neoplasms | 8 | 2025 | 1145 | 1.070 |
Why?
| | Child | 57 | 2025 | 20884 | 1.040 |
Why?
| | Neural Tube Defects | 2 | 2018 | 59 | 1.010 |
Why?
| | Fetus | 6 | 2022 | 774 | 0.930 |
Why?
| | Craniopharyngioma | 5 | 2025 | 74 | 0.930 |
Why?
| | Turbinates | 1 | 2024 | 16 | 0.920 |
Why?
| | Retrospective Studies | 36 | 2025 | 14522 | 0.900 |
Why?
| | Nervous System Malformations | 2 | 2023 | 38 | 0.890 |
Why?
| | Head and Neck Neoplasms | 3 | 2022 | 544 | 0.870 |
Why?
| | Placenta Accreta | 1 | 2024 | 26 | 0.860 |
Why?
| | Central Nervous System Neoplasms | 2 | 2022 | 148 | 0.850 |
Why?
| | Megalencephaly | 1 | 2022 | 19 | 0.790 |
Why?
| | Circle of Willis | 1 | 2022 | 7 | 0.780 |
Why?
| | Epidermal Cyst | 1 | 2022 | 12 | 0.770 |
Why?
| | Dermoid Cyst | 1 | 2022 | 15 | 0.770 |
Why?
| | Contrast Media | 4 | 2022 | 393 | 0.760 |
Why?
| | Infant | 23 | 2025 | 8995 | 0.750 |
Why?
| | Humans | 102 | 2025 | 129625 | 0.740 |
Why?
| | Child, Preschool | 31 | 2025 | 10490 | 0.740 |
Why?
| | Pituitary Neoplasms | 4 | 2025 | 179 | 0.730 |
Why?
| | Nasal Obstruction | 1 | 2021 | 27 | 0.710 |
Why?
| | Neck | 4 | 2022 | 95 | 0.700 |
Why?
| | Infant, Newborn, Diseases | 2 | 2019 | 110 | 0.690 |
Why?
| | Central Nervous System Infections | 2 | 2018 | 35 | 0.680 |
Why?
| | Ependymoma | 1 | 2022 | 161 | 0.680 |
Why?
| | Gadolinium DTPA | 2 | 2019 | 51 | 0.680 |
Why?
| | Intracranial Hemorrhages | 2 | 2019 | 78 | 0.670 |
Why?
| | Temporal Lobe | 1 | 2019 | 86 | 0.630 |
Why?
| | Cavernous Sinus Thrombosis | 2 | 2015 | 9 | 0.610 |
Why?
| | Thrombosis | 1 | 2022 | 348 | 0.610 |
Why?
| | Anatomic Landmarks | 1 | 2018 | 28 | 0.610 |
Why?
| | Occipital Lobe | 1 | 2017 | 23 | 0.570 |
Why?
| | Female | 52 | 2025 | 68734 | 0.560 |
Why?
| | Spinal Cord | 2 | 2021 | 353 | 0.550 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 105 | 0.530 |
Why?
| | Facial Injuries | 1 | 2016 | 18 | 0.530 |
Why?
| | Pediatrics | 4 | 2019 | 1056 | 0.520 |
Why?
| | Frontal Lobe | 1 | 2017 | 154 | 0.520 |
Why?
| | Head | 2 | 2019 | 96 | 0.510 |
Why?
| | Brain Diseases | 2 | 2020 | 136 | 0.510 |
Why?
| | Carotid Stenosis | 2 | 2015 | 84 | 0.510 |
Why?
| | Pregnancy | 14 | 2025 | 6417 | 0.510 |
Why?
| | Societies, Medical | 6 | 2022 | 744 | 0.500 |
Why?
| | Spinal Injuries | 3 | 2022 | 51 | 0.500 |
Why?
| | Tissue Adhesions | 1 | 2015 | 30 | 0.500 |
Why?
| | Lymphatic Abnormalities | 2 | 2012 | 19 | 0.490 |
Why?
| | Cerebral Infarction | 1 | 2015 | 42 | 0.480 |
Why?
| | Craniofacial Abnormalities | 2 | 2012 | 63 | 0.480 |
Why?
| | Ultrasonography, Prenatal | 3 | 2022 | 274 | 0.470 |
Why?
| | Central Nervous System Diseases | 1 | 2015 | 69 | 0.470 |
Why?
| | Hypothalamus | 1 | 2015 | 149 | 0.470 |
Why?
| | Prevalence | 5 | 2024 | 2564 | 0.440 |
Why?
| | Infant, Newborn | 14 | 2022 | 5756 | 0.440 |
Why?
| | Male | 40 | 2025 | 63670 | 0.420 |
Why?
| | Dandy-Walker Syndrome | 2 | 2023 | 7 | 0.420 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2023 | 210 | 0.410 |
Why?
| | Stomatognathic Diseases | 1 | 2012 | 4 | 0.400 |
Why?
| | Goiter | 1 | 2012 | 4 | 0.400 |
Why?
| | Adolescent | 22 | 2025 | 20412 | 0.400 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2025 | 99 | 0.370 |
Why?
| | Meningomyelocele | 2 | 2022 | 55 | 0.370 |
Why?
| | Brain Ischemia | 3 | 2022 | 321 | 0.360 |
Why?
| | Magnetic Resonance Angiography | 3 | 2019 | 234 | 0.360 |
Why?
| | Fetal Diseases | 1 | 2012 | 158 | 0.360 |
Why?
| | Sinusitis | 3 | 2018 | 211 | 0.350 |
Why?
| | Diagnosis, Differential | 7 | 2019 | 1432 | 0.330 |
Why?
| | Sacrum | 3 | 2018 | 74 | 0.330 |
Why?
| | Emergency Medical Services | 1 | 2015 | 522 | 0.320 |
Why?
| | Infarction, Middle Cerebral Artery | 3 | 2022 | 39 | 0.320 |
Why?
| | Postoperative Complications | 2 | 2018 | 2477 | 0.320 |
Why?
| | Hypothalamic Diseases | 2 | 2022 | 18 | 0.320 |
Why?
| | Neurodevelopmental Disorders | 2 | 2025 | 155 | 0.300 |
Why?
| | Anorectal Malformations | 2 | 2021 | 109 | 0.290 |
Why?
| | Evidence-Based Medicine | 6 | 2022 | 712 | 0.290 |
Why?
| | Mitochondrial Diseases | 2 | 2020 | 90 | 0.290 |
Why?
| | Placenta | 2 | 2025 | 723 | 0.290 |
Why?
| | Prenatal Care | 4 | 2022 | 277 | 0.290 |
Why?
| | Brain Injuries, Traumatic | 2 | 2025 | 341 | 0.280 |
Why?
| | Gestational Age | 4 | 2025 | 876 | 0.280 |
Why?
| | Teratoma | 2 | 2019 | 103 | 0.270 |
Why?
| | Cerebrovascular Disorders | 2 | 2020 | 90 | 0.260 |
Why?
| | Muscular Diseases | 2 | 2020 | 107 | 0.260 |
Why?
| | Priapism | 1 | 2005 | 11 | 0.250 |
Why?
| | Chloroquine | 2 | 2017 | 51 | 0.240 |
Why?
| | Penis | 1 | 2005 | 35 | 0.240 |
Why?
| | Hematoma, Subdural | 2 | 2022 | 17 | 0.240 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 24 | 0.230 |
Why?
| | Sotos Syndrome | 1 | 2024 | 2 | 0.230 |
Why?
| | Malformations of Cortical Development | 1 | 2024 | 13 | 0.230 |
Why?
| | Glycosylphosphatidylinositols | 1 | 2024 | 11 | 0.230 |
Why?
| | Brain Edema | 1 | 2025 | 60 | 0.230 |
Why?
| | Nasal Septum | 1 | 2024 | 25 | 0.230 |
Why?
| | Placental Circulation | 1 | 2025 | 65 | 0.230 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2025 | 98 | 0.220 |
Why?
| | Microvessels | 1 | 2025 | 82 | 0.220 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2046 | 0.220 |
Why?
| | Disease Progression | 2 | 2024 | 2627 | 0.210 |
Why?
| | Tumor Burden | 1 | 2024 | 286 | 0.210 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2020 | 34 | 0.210 |
Why?
| | Embolization, Therapeutic | 1 | 2005 | 207 | 0.210 |
Why?
| | Phenotype | 4 | 2024 | 3075 | 0.210 |
Why?
| | Autophagy | 2 | 2017 | 266 | 0.210 |
Why?
| | Physical Abuse | 1 | 2023 | 39 | 0.200 |
Why?
| | Indoles | 2 | 2017 | 383 | 0.200 |
Why?
| | Neck Injuries | 1 | 2022 | 21 | 0.200 |
Why?
| | Surface Plasmon Resonance | 1 | 2022 | 89 | 0.200 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2022 | 24 | 0.200 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 234 | 0.190 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.190 |
Why?
| | Pyrimidinones | 1 | 2023 | 102 | 0.190 |
Why?
| | Decision Support Systems, Clinical | 1 | 2025 | 205 | 0.190 |
Why?
| | Artificial Intelligence | 1 | 2025 | 245 | 0.190 |
Why?
| | Sulfonamides | 2 | 2017 | 497 | 0.190 |
Why?
| | Cysts | 1 | 2022 | 109 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2023 | 101 | 0.190 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 70 | 0.180 |
Why?
| | Neuroblastoma | 1 | 2022 | 151 | 0.180 |
Why?
| | Epilepsy | 2 | 2016 | 322 | 0.180 |
Why?
| | Pyridones | 1 | 2023 | 158 | 0.180 |
Why?
| | White Matter | 1 | 2023 | 135 | 0.180 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 95 | 0.180 |
Why?
| | Methionine | 1 | 2021 | 155 | 0.180 |
Why?
| | Seizures | 3 | 2024 | 401 | 0.180 |
Why?
| | Vitamin B 12 | 1 | 2021 | 122 | 0.180 |
Why?
| | Pituitary Diseases | 1 | 2020 | 21 | 0.180 |
Why?
| | Glioma | 1 | 2025 | 348 | 0.180 |
Why?
| | Sutures | 1 | 2021 | 53 | 0.180 |
Why?
| | Nasal Cavity | 1 | 2021 | 51 | 0.170 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2020 | 17 | 0.170 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2020 | 36 | 0.170 |
Why?
| | Arnold-Chiari Malformation | 1 | 2020 | 27 | 0.170 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.170 |
Why?
| | Leigh Disease | 1 | 2020 | 19 | 0.170 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.170 |
Why?
| | Pituitary Gland | 1 | 2020 | 148 | 0.170 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 86 | 0.160 |
Why?
| | Tyrosine | 1 | 2020 | 223 | 0.160 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 778 | 0.160 |
Why?
| | United States | 11 | 2025 | 13871 | 0.160 |
Why?
| | Spasms, Infantile | 1 | 2021 | 122 | 0.160 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 42 | 0.160 |
Why?
| | RNA, Transfer | 1 | 2020 | 130 | 0.160 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 191 | 0.160 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 11 | 0.160 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.160 |
Why?
| | Fetal Growth Retardation | 1 | 2025 | 550 | 0.160 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2020 | 73 | 0.160 |
Why?
| | Taenia solium | 1 | 2018 | 5 | 0.150 |
Why?
| | Foramen Magnum | 1 | 2018 | 8 | 0.150 |
Why?
| | Neurocysticercosis | 1 | 2018 | 8 | 0.150 |
Why?
| | Ilium | 1 | 2018 | 29 | 0.150 |
Why?
| | Occipital Bone | 1 | 2018 | 18 | 0.150 |
Why?
| | Radiology | 1 | 2020 | 159 | 0.150 |
Why?
| | Sphenoid Bone | 1 | 2018 | 15 | 0.150 |
Why?
| | Skull Base | 1 | 2018 | 46 | 0.150 |
Why?
| | Developmental Disabilities | 2 | 2024 | 261 | 0.150 |
Why?
| | Soft Tissue Neoplasms | 1 | 2019 | 111 | 0.150 |
Why?
| | Area Under Curve | 1 | 2018 | 304 | 0.140 |
Why?
| | Reference Values | 1 | 2019 | 794 | 0.140 |
Why?
| | Toxoplasmosis | 1 | 2018 | 37 | 0.140 |
Why?
| | Fecal Incontinence | 1 | 2018 | 80 | 0.140 |
Why?
| | Radiation Dosage | 1 | 2019 | 154 | 0.140 |
Why?
| | Adenoidectomy | 1 | 2018 | 65 | 0.140 |
Why?
| | Epilepsies, Partial | 1 | 2018 | 44 | 0.140 |
Why?
| | Olfaction Disorders | 1 | 2018 | 60 | 0.140 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 8 | 0.140 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 1843 | 0.140 |
Why?
| | Central Nervous System | 2 | 2022 | 255 | 0.140 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2018 | 128 | 0.140 |
Why?
| | Common Data Elements | 1 | 2017 | 12 | 0.140 |
Why?
| | Adult | 10 | 2025 | 35599 | 0.140 |
Why?
| | Herpes Simplex | 1 | 2018 | 92 | 0.140 |
Why?
| | Coccyx | 1 | 2017 | 5 | 0.140 |
Why?
| | Mitochondria | 2 | 2020 | 876 | 0.140 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 8 | 0.140 |
Why?
| | ROC Curve | 1 | 2018 | 503 | 0.130 |
Why?
| | Fetal Movement | 1 | 2016 | 6 | 0.130 |
Why?
| | Cerebral Arteries | 1 | 2017 | 60 | 0.130 |
Why?
| | Fetal Monitoring | 1 | 2016 | 15 | 0.130 |
Why?
| | Drug Resistant Epilepsy | 1 | 2018 | 82 | 0.130 |
Why?
| | Diazepam | 1 | 2016 | 34 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 148 | 0.130 |
Why?
| | Organ Size | 1 | 2017 | 446 | 0.130 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 282 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 528 | 0.130 |
Why?
| | Spondylolysis | 1 | 2016 | 7 | 0.130 |
Why?
| | Anti-Anxiety Agents | 1 | 2016 | 45 | 0.130 |
Why?
| | Olfactory Bulb | 1 | 2018 | 136 | 0.130 |
Why?
| | Osteomyelitis | 1 | 2018 | 121 | 0.130 |
Why?
| | Cytomegalovirus Infections | 1 | 2018 | 189 | 0.130 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2020 | 740 | 0.130 |
Why?
| | Balamuthia mandrillaris | 1 | 2015 | 4 | 0.130 |
Why?
| | Amebiasis | 1 | 2015 | 5 | 0.130 |
Why?
| | Genome, Microbial | 1 | 2015 | 7 | 0.130 |
Why?
| | Fracture Fixation | 1 | 2016 | 78 | 0.130 |
Why?
| | Intracranial Thrombosis | 1 | 2015 | 16 | 0.130 |
Why?
| | Third Ventricle | 1 | 2015 | 17 | 0.120 |
Why?
| | Hamartoma | 1 | 2015 | 21 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 101 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 155 | 0.120 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 26 | 0.120 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 93 | 0.120 |
Why?
| | Eye Infections, Fungal | 1 | 2015 | 7 | 0.120 |
Why?
| | Endocrine System Diseases | 1 | 2015 | 33 | 0.120 |
Why?
| | Headache | 3 | 2023 | 151 | 0.120 |
Why?
| | Orbital Cellulitis | 1 | 2015 | 15 | 0.120 |
Why?
| | Encephalomyelitis, Acute Disseminated | 1 | 2015 | 11 | 0.120 |
Why?
| | Onchocerciasis | 1 | 2015 | 5 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 340 | 0.120 |
Why?
| | Eye Infections, Bacterial | 1 | 2015 | 27 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.120 |
Why?
| | Pyridoxine | 1 | 2015 | 32 | 0.120 |
Why?
| | Perioperative Care | 1 | 2016 | 151 | 0.120 |
Why?
| | Software | 1 | 2020 | 608 | 0.120 |
Why?
| | Vitamin B Complex | 1 | 2015 | 41 | 0.120 |
Why?
| | Spinal Cord Diseases | 1 | 2015 | 41 | 0.120 |
Why?
| | Emergencies | 1 | 2015 | 156 | 0.120 |
Why?
| | Cohort Studies | 3 | 2024 | 5426 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2017 | 752 | 0.110 |
Why?
| | Paralysis | 1 | 2015 | 69 | 0.110 |
Why?
| | Cranial Nerve Diseases | 1 | 2014 | 42 | 0.110 |
Why?
| | Paraplegia | 1 | 2014 | 57 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 229 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2014 | 48 | 0.110 |
Why?
| | Fetal Therapies | 1 | 2014 | 31 | 0.110 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 234 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 2017 | 251 | 0.110 |
Why?
| | Encephalitis | 1 | 2015 | 132 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1499 | 0.110 |
Why?
| | Arginine | 1 | 2015 | 263 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 64 | 0.110 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 129 | 0.110 |
Why?
| | Hippocampus | 1 | 2018 | 873 | 0.110 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2015 | 252 | 0.100 |
Why?
| | Enterovirus D, Human | 1 | 2014 | 82 | 0.100 |
Why?
| | Otitis Media | 1 | 2015 | 160 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2060 | 0.100 |
Why?
| | Lysine | 1 | 2015 | 286 | 0.100 |
Why?
| | Pharyngeal Diseases | 1 | 2012 | 15 | 0.100 |
Why?
| | Logistic Models | 1 | 2017 | 1986 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2016 | 580 | 0.100 |
Why?
| | HIV Infections | 2 | 2018 | 2730 | 0.090 |
Why?
| | Enterovirus Infections | 1 | 2014 | 171 | 0.090 |
Why?
| | Cranial Fossa, Posterior | 2 | 2022 | 17 | 0.090 |
Why?
| | Amino Acids | 1 | 2015 | 487 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2018 | 3378 | 0.090 |
Why?
| | Incidence | 1 | 2017 | 2641 | 0.090 |
Why?
| | Young Adult | 4 | 2024 | 12455 | 0.090 |
Why?
| | Mutation | 5 | 2021 | 3717 | 0.090 |
Why?
| | Brain Injuries | 1 | 2015 | 466 | 0.090 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 57 | 0.090 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 331 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2014 | 317 | 0.080 |
Why?
| | Cerebellum | 2 | 2022 | 218 | 0.080 |
Why?
| | Ultrasonography | 2 | 2021 | 712 | 0.080 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1705 | 0.080 |
Why?
| | Physical Examination | 2 | 2023 | 234 | 0.080 |
Why?
| | Brain Stem | 2 | 2023 | 99 | 0.080 |
Why?
| | Cervical Vertebrae | 2 | 2022 | 132 | 0.070 |
Why?
| | Prognosis | 3 | 2023 | 3774 | 0.070 |
Why?
| | Cerebrospinal Fluid | 2 | 2018 | 91 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2739 | 0.060 |
Why?
| | Family | 2 | 2021 | 646 | 0.060 |
Why?
| | Recurrence | 2 | 2022 | 1011 | 0.060 |
Why?
| | Risk Factors | 4 | 2022 | 9786 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2022 | 4894 | 0.060 |
Why?
| | Angiography | 1 | 2005 | 196 | 0.060 |
Why?
| | Drug Synergism | 2 | 2017 | 370 | 0.060 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2024 | 10 | 0.060 |
Why?
| | Endarterectomy, Carotid | 1 | 2004 | 47 | 0.060 |
Why?
| | Glasgow Coma Scale | 1 | 2025 | 165 | 0.060 |
Why?
| | Spinal Fractures | 1 | 2005 | 83 | 0.060 |
Why?
| | Radiography, Interventional | 1 | 2004 | 105 | 0.050 |
Why?
| | Europe | 1 | 2025 | 363 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2024 | 208 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2025 | 205 | 0.050 |
Why?
| | Algorithms | 2 | 2022 | 1616 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2004 | 196 | 0.050 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 124 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2025 | 509 | 0.050 |
Why?
| | Ataxia | 1 | 2022 | 42 | 0.050 |
Why?
| | Intellectual Disability | 1 | 2024 | 155 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 13 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 43 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 7135 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 216 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 24 | 0.050 |
Why?
| | Wounds, Gunshot | 1 | 2005 | 213 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 17 | 0.050 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 22 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2022 | 183 | 0.050 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 40 | 0.050 |
Why?
| | Retinal Hemorrhage | 1 | 2021 | 19 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 133 | 0.040 |
Why?
| | Homocysteine | 1 | 2021 | 152 | 0.040 |
Why?
| | Radiography | 1 | 2023 | 797 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 41 | 0.040 |
Why?
| | Neuroradiography | 1 | 2020 | 5 | 0.040 |
Why?
| | Stents | 1 | 2004 | 504 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 233 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 115 | 0.040 |
Why?
| | Anal Canal | 1 | 2021 | 88 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 96 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 46 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3080 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 188 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 195 | 0.040 |
Why?
| | Sacrococcygeal Region | 1 | 2019 | 7 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2020 | 283 | 0.040 |
Why?
| | Skull Fractures | 1 | 2019 | 33 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 64 | 0.040 |
Why?
| | Radiation Exposure | 1 | 2019 | 45 | 0.040 |
Why?
| | Antibodies, Helminth | 1 | 2018 | 6 | 0.040 |
Why?
| | Diaper Rash | 1 | 2018 | 4 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 68 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 845 | 0.040 |
Why?
| | Kallmann Syndrome | 1 | 2018 | 8 | 0.040 |
Why?
| | Hemispherectomy | 1 | 2018 | 2 | 0.040 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2018 | 17 | 0.040 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2018 | 35 | 0.040 |
Why?
| | Urinary Incontinence | 1 | 2018 | 62 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 509 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 79 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 3186 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2017 | 2373 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2018 | 326 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1035 | 0.040 |
Why?
| | Constipation | 1 | 2018 | 88 | 0.040 |
Why?
| | Meningitis | 1 | 2018 | 79 | 0.030 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2017 | 3 | 0.030 |
Why?
| | Overweight | 1 | 2022 | 531 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 325 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 487 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2020 | 546 | 0.030 |
Why?
| | Trauma Centers | 1 | 2019 | 402 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 272 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1645 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 495 | 0.030 |
Why?
| | Rhinitis | 1 | 2018 | 152 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1028 | 0.030 |
Why?
| | Eosinophilia | 1 | 2018 | 204 | 0.030 |
Why?
| | Labor, Obstetric | 1 | 2016 | 58 | 0.030 |
Why?
| | Oximetry | 1 | 2016 | 87 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 10219 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 869 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 77 | 0.030 |
Why?
| | Mucormycosis | 1 | 2015 | 22 | 0.030 |
Why?
| | Electroencephalography | 1 | 2018 | 409 | 0.030 |
Why?
| | Diet Therapy | 1 | 2015 | 34 | 0.030 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2015 | 57 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 168 | 0.030 |
Why?
| | Metagenomics | 1 | 2015 | 156 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1560 | 0.030 |
Why?
| | Data Collection | 1 | 2017 | 650 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1076 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2274 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2015 | 177 | 0.030 |
Why?
| | Streptococcal Infections | 1 | 2015 | 148 | 0.030 |
Why?
| | Visual Acuity | 1 | 2015 | 327 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 382 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 542 | 0.020 |
Why?
| | Acute Disease | 1 | 2015 | 979 | 0.020 |
Why?
| | Animals | 3 | 2021 | 35391 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 220 | 0.020 |
Why?
| | Branchial Region | 1 | 2012 | 36 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1042 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5075 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1947 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1491 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 349 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 3152 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2688 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1198 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2015 | 534 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 640 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 1045 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1613 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4404 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 389 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1122 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 972 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6555 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2882 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 5415 | 0.020 |
Why?
| | Polymethyl Methacrylate | 1 | 2005 | 22 | 0.020 |
Why?
| | Aged | 2 | 2019 | 22061 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 175 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 31136 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 7052 | 0.010 |
Why?
|
|
Mirsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|